Skip to content
FrontierPicks

Dossier · PCTY · Dormant

PCTY · Paylocity Holding Corporation · Stock research

Last analysed ·

Resolved Graded and closed 2026-08-20 at medium conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-08-22 and is not part of the scored record.

Current thesis

Post-print re-rating leg: the 2026-08-04 Q4 FY26 beat ($1.84 adj. EPS vs $1.61 est.) triggered five price-target raises in 48 hours and a $150.42 close on 2026-08-07, +35.5% over three months. The buy is multiple recovery in mid-cap HCM software, paid for against an FY27 guide that steps recurring growth down from 12.2% to ~8%.

Kill line

A weekly close below $140 (fills the 2026-08-04 post-print gap and returns PCTY to its pre-earnings range); secondarily, any cut to the $1.777B FY27 recurring & other revenue floor at the Q1 FY27 print in late October.

Pick status

Played out resolved published kill line did not fire How this is scored →

Latest analysis and events for PCTY —

As of 22 August 2026, the latest FrontierPicks analysis for Paylocity Holding Corporation (PCTY): Post-print re-rating leg: the 2026-08-04 Q4 FY26 beat ($1.84 adj. EPS vs $1.61 est.) triggered five price-target raises in 48 hours and a $150.42 close on 2026-08-07, +35.5% over three months. The buy is multiple recovery in mid-cap HCM software, paid for against an FY27 guide that steps recurring growth down from 12.2% to ~8%.

Kill line: A weekly close below $140 (fills the 2026-08-04 post-print gap and returns PCTY to its pre-earnings range); secondarily, any cut to the $1.777B FY27 recurring & other revenue floor at the Q1 FY27 print in late October.

Current Thesis

The post-print re-rating leg from the 2026-08-04 Q4 FY26 beat is still intact and has flattened. The stock closed $150.42 on 2026-08-07 and $153.34 on 2026-08-21, with RSI(14) easing from 71.1 to 66.6 over the same stretch — higher price, lower momentum reading. Sell-side is still marking up: TD Cowen went to $177 from $168 on 2026-08-20, its second raise in fifteen days. What an investor is buying here is the second half of a multiple recovery in mid-cap HCM software, against an FY27 guide that steps recurring growth from 12.2% down to roughly 8%, and with no company-dated event on the calendar — the FY26 Form 10-K was filed 2026-08-05, which cleared the last interim document ahead of the Q1 FY27 print in late October.

Bullish and bearish views on Paylocity Holding Corporation

The model's bull view on Paylocity Holding Corporation (PCTY), in brief: The sell-side reset did not stop at the print. The bear view: The deceleration is contractual, not atmospheric. Both cases follow in full.

Bull Case

  • The sell-side reset did not stop at the print. TD Cowen raised to $177 from $168 with a Buy rating on 2026-08-20, after the 2026-08-05/06 wave: BTIG $180, KeyBanc $178, TD Cowen $168, Cantor Fitzgerald $165, Barclays $154. BMO Capital Markets is reported at $175 (Outperform, up from $143) in August 2026 coverage.
  • FY26 10-K, filed 2026-08-05: revenue $1.77B (+11% YoY), net income $269.74M (+18.8%), diluted GAAP EPS $4.92 (+22.4% from $4.02). Client base roughly 44,400, about +7% organic; annual revenue retention above 92%.
  • Q4 FY26 beat, 2026-08-04: total revenue $444.7M (+11.0% YoY), recurring & other revenue $415.6M (+12.4%), non-GAAP EPS $1.84 against $1.61 consensus.
  • Q1 FY27 guidance came in over the estimate: total revenue $439.5M–$444.5M versus $438.482M consensus; recurring & other revenue $414.0M–$419.0M, characterised by management as ~10% growth.
  • FY27 profit guide sits above the FY26 actual: Adjusted EBITDA $690.0M–$700.0M versus FY26's $654.9M (37.0% of total revenue); excluding client fund interest, $587.0M–$597.0M.
  • Cash conversion and a shrinking share count: FY26 operating cash flow $533.3M, free cash flow $427.8M, cash and equivalents $271.9M against $81.3M long-term debt; FY26 repurchases $398.1M / 2.8M shares, cumulative $697.8M / 4.6M shares since May 2024.
  • The post-print gap has not been surrendered: closes of $147.81 (2026-08-05), $150.42 (2026-08-07) and $153.34 (2026-08-21) sit above the pre-earnings range.

Bear Case

  • The deceleration is contractual, not atmospheric. FY27 recurring & other revenue is guided $1.777B–$1.792B (~8%) against FY26 actual $1.651B (+12.2%); FY27 total revenue $1.880B–$1.895B (~7%) against FY26's $1.771B (+11.0%).
  • Total revenue is guided to grow slower than recurring revenue, which puts client fund interest income — float on client payroll balances — on a declining path outside management's control.
  • Roughly 120–140bp of the FY27 margin guide is a convention change: from FY27 deferred contract costs amortize over 8 years rather than 7, disclosed 2026-08-04. FY27 Adjusted EBITDA margin is not comparable to FY26 on a like-for-like accounting.
  • Price is now inside the sell-side band rather than beneath it. MarketBeat's compilation cited in 2026-08-20 coverage shows a consensus average target of $160.53 with 12 Buy and 5 Hold ratings, versus the 2026-08-21 close of $153.34. Dispersion remains wide: UBS Neutral $128 on 2026-07-22 against BTIG $180.
  • The trailing-quarter gain has stopped compounding. The pipeline series shows a three-month price change of 35.7% as of 2026-08-21 versus 35.5% as of 2026-08-07 — inference: the measurement window rolled forward onto a higher starting point and the last two weeks added little.
  • Overhead supply is unresolved: the last close sits 15.9% under the $182.31 52-week high, and the ground between is held by prior owners.

Setup & Price Structure

  • Reference close $153.34 on 2026-08-21. 52-week high $182.31, leaving the stock 15.9% below it. Three-month price change of 35.7%. RSI(14) at 66.6.
  • Momentum reading has cooled while price rose: RSI 71.1 at the $150.42 close on 2026-08-07, 66.6 at $153.34 on 2026-08-21. Measured, not interpreted — participation in the leg is narrowing rather than broadening.
  • The structure to watch is the 2026-08-04 print gap. The first post-print close was $147.81 on 2026-08-05 (+3.1% on a 14.2% EPS beat, a muted reaction), and every close since has held above that shelf. The $140 area is where the gap fills and the stock re-enters its pre-earnings range.
  • Upside reference points are all third-party marks: the $160.53 consensus average, then the $165–$180 target cluster (Cantor $165, TD Cowen $177, KeyBanc $178, BTIG $180), then the $182.31 52-week high.
  • Crowding observables. Coverage clustering is analyst-action wire traffic (Benzinga, TipRanks, MarketBeat compilations) rather than retail-forum flow — this is not a message-board name. Seventeen rated sell-side opinions split 12 Buy / 5 Hold. Insider supply is plan-driven and continuous through August at $148–$156. The company itself repurchased $398.1M in FY26. There is no earnings date inside 30 days, so there is no print to compress positioning into.
  • The narrative is maturing. Attention peaked with the 2026-08-04 print and the 2026-08-05/06 target wave; the narrative is still working (TD Cowen's 2026-08-20 raise, price higher on 2026-08-21 than on 2026-08-07); flow is moderating (RSI 71.1 → 66.6, a two-week price gain of under three dollars, last close below the consensus average target). It is not saturated — the coverage is institutional and the stock remains 15.9% below its own 52-week high — and it is not accelerating, because the fresh-headline supply ended with the 10-K on 2026-08-05.

Catalyst Calendar (next 30 days)

  • ~2026-09-04 (est.) — August US employment situation (BLS). Paylocity bills partly per employee per month, so mid-market payroll counts feed recurring revenue with a lag; the ~8% FY27 recurring guide assumes a stable installed base.
  • ~2026-09-16 (est.) — FOMC decision. Client fund interest income is already guided lower in FY27, and front-end rates determine how much of the $690M–$700M Adjusted EBITDA guide comes from float versus operations.
  • ~2026-10-29 (est.) — Q1 FY27 earnings. Outside the 30-day window and the only company-specific binary between now and then.

Elapsed catalysts

  • No company-dated event inside the window. The FY26 Form 10-K (fiscal year ended 2026-06-30) was filed 2026-08-05; the estimated late-August filing date carried in earlier coverage has come and gone. (passed 21d ago)

What Would Change Our Mind

The thing that has to hold is the 2026-08-04 print gap and the $147.81–$150.42 shelf built on top of it; losing that returns the stock to the range it traded in before the beat, and the re-rating argument goes with it. Concretely, a weekly close below $140 fills the gap and ends the leg. Ahead of that, a sustained set of daily closes back under the $147 area would say the post-print shelf failed as support.

On fundamentals, the read breaks if Q1 FY27 recurring & other revenue prints below the guided $414.0M floor in late October, or if the FY27 recurring range is cut below $1.777B. Two operating markers from the 2026-08-04 call would flag it earlier: average revenue per client falling sequentially from ~$37,200, or revenue retention slipping below the 92% level management has cited. A downgrade cycle — the same shops that moved to $165–$180 in August cutting back toward the UBS $128 mark — would show the sell-side leg reversing.

What would strengthen the case instead: weekly closes established above the $160.53 consensus average with the momentum reading holding, which would mean the market is pricing the FY27 guide as an opening bid rather than a ceiling.

Correlation Notes

  • Moves with the mid-market HCM complex — PAYC, PAYX, ADP — and with the broader mid-cap SaaS multiple. A peer's guidance on mid-market wins reads directly onto Paylocity's ~7% client-count growth.
  • Carries two-sided rate exposure that pure software peers do not: falling front-end rates compress client fund interest income (a revenue line) while typically supporting software multiples. The offset happens inside the same ticker, so a rate-cut headline is not a clean directional input.
  • Employment-linked. Per-employee-per-month billing means US mid-market payroll counts move recurring revenue independent of new-logo wins, which gives the name labor-cycle beta on top of software beta.
  • Fiscal calendar is offset from the peer group: fiscal year ends June 30, so what the company calls Q1 FY27 is the September quarter and lands in late October.

Notes

  • Fiscal year ends June 30. "Q1 FY27" is the September quarter and is reported in late October, not the calendar-Q1 print.
  • Client fund interest income (float on client payroll balances) is reported separately from recurring & other revenue and moves with front-end rates.
  • From FY27 deferred contract costs amortize over 8 years instead of 7, worth ~120-140bp to FY27 Adjusted EBITDA margin. FY27 margins are not comparable to FY26.
  • Revenue is partly per-employee-per-month, so client headcount changes flow into recurring revenue independent of new-logo wins.
  • Director and >10% holder Steven Sarowitz sells under a Rule 10b5-1 plan adopted 2025-12-15; his August sales are pre-scheduled rather than discretionary.
  • FY26 Form 10-K was filed 2026-08-05, one day after the Q4 release, so there is no separate late-August filing event.

Related · shared themes

OKTA

Okta, Inc.

Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme accelerating, this leg maturing; open risk is paying up for a stretched 52-week-high tape.

MEDIUM

HNGE

Hinge Health, Inc.

Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.

LOW

HPE

Hewlett Packard Enterprise Company

The one green close failed: 2026-08-24 closed $52.43, undercutting the 08-20 low close of $52.89 and marking seven of eight sessions lower off the 2026-08-13 high of $59.82, with no dated HPE news since 2026-08-19. The 2026-09-02 Q3 print is the binary — screens carry ~$0.93–0.94 EPS on ~$11.97B against a $0.88–0.93 / $11.5–12.1B guide. The narrative is saturated.

LOW

SNX

TD SYNNEX Corporation

Second-order AI re-rating still unconfirmed by company data, and the tape has now taken it back: the 2026-08-24 close of $243.65 leaves a three-month price change of +1.7% with RSI(14) at 27.3. The 11-analyst panel has not revised since 2026-07-22, across five external events. NVDA on 2026-08-26 re-prices the complex a month before TD SYNNEX discloses anything.

LOW

See also · stocks to watch